A novel C-3-substituted oleanolic acid benzyl amide derivative exhibits therapeutic potential against influenza A by targeting PA-PB1 interactions and modulating host macrophage inflammation.

Acta Pharm Sin B · 2025 · PMC12399203 · PMID 40893672

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The number of CD11c + plasmacytoid dendritic cells and Ly6G + monocytes in the spleens of A5 -treated mice was lower than that in the model group, although the difference did not reach statistical significance (Supporting Information Fig.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.